You just read:

Takeda Drives Leading PAMES Study in Brazil Showing Improved Symptom Relief for People with Erosive Gastroesophageal Reflux Disease (GERD)

News provided by

Takeda Pharmaceuticals International GmbH

Dec 12, 2013, 06:01 ET